Artificial Intelligence has multiple applications in the healthcare domain. We have also seen many AI solutions being developed to identify symptoms of COVID-19 among patients. Here’s one such case of AI-based screening of visitors at Mumbai railway stations to identify COVID-19 symptoms. Also, the application of Artificial Intelligence in adjusting insulin dose to control glucose levels among Type I Diabetes patients.
Body-screening facility “FebriEye thermal cameras” have been set up at Chhatrapati Shivaji Maharaj Terminus and Lokmanya Tilak Terminus in Mumbai to scan passengers for COVID-19 symptoms.
FebriEye is an AI-based thermal screening system for real-time and non-intrusive thermal monitoring. It ensures that a person entering the premises does not have a high fever. It uses heat sensors that record the heat generated by a human entity and creates a 2D image showing different temperature levels.
The FebriEye thermal cameras cover a large area and are able to detect the temperature of multiple people entering simultaneously. It records temperature automatically while the passengers are moving.
Researchers at Oregon Health and Science University have designed an Artificial Intelligence-based method to help people with Type I diabetes manage their glucose levels. The AI algorithm also takes into account automated monitoring and uses data collected from a continuous glucose monitor and wireless insulin pens to guide on adjustments.
The algorithm is paired with a smartphone app called DailyDose. This model will help reduce hypoglycemia (low glucose) which can cause coma or death if left untreated.
In addition to glucose control, The algorithm generated recommendations had a high correlation with physician recommendations. Over 99% recommendations by the algorithm, delivered across 100 weeks of patient testing, were deemed safe by the physicians.
If you are interested in the domain of AI and want to learn more about the subject, check out Great Learning’s PG program in Artificial Intelligence and Machine Learning.